In an unusual acquisition within the ETF space, the investment arm behind former President Donald Trump's social media platform is set to purchase the conservative-themed 'God Bless America' ETF, significantly expanding its asset base and adding active management to its lineup.
New clinical imaging data for Molecular Partners' experimental radiotherapeutic MP0712, targeting the DLL3 protein in cancers like small cell lung cancer, show favorable tumor targeting and healthy organ clearance. The company confirms its U.S. Phase I/II trial is now open for patient screening.
Former President Donald Trump's recent comments advocating for higher housing prices have ignited debate, as experts warn such a stance could deepen the affordability crisis for younger generations and renters.
A significant reset in analyst price targets for iRhythm Holdings (IRTC) is prompting investors to reassess the cardiac monitoring firm's risk-reward profile. This shift reflects evolving views on reimbursement headwinds, competitive pressures, and long-term growth catalysts in the digital health sector.
Abbott Laboratories moves to acquire cancer-testing leader Exact Sciences in a landmark deal, signaling a strategic shift toward high-growth diagnostics while simultaneously restructuring its challenged Nutrition business.
Novo Nordisk launches its first oral GLP-1 weight-loss drug with strong early demand, reports positive Phase 3 results for CagriSema, and expands a cell therapy partnership for diabetes. These moves come as investors reevaluate the company's long-term growth prospects amid competitive and pricing pressures.
Fifth Third Bancorp has finalized its $12.3 billion acquisition of Comerica Bank, with customer system conversions and branch rebranding scheduled to begin after Labor Day. The deal reshapes Michigan's banking landscape and creates the nation's ninth-largest bank.
London's blue-chip index surged to a historic high as investors rotated into defensive sectors, shrugging off a brutal sell-off in precious metals and oil triggered by geopolitical shifts and regulatory moves.
As inflation persists, Baby Boomers are leveraging decades of financial experience to cut costs strategically. We examine the key spending categories they avoid and the generational mindset behind their money choices.
Sugar futures extended their sharp decline this week, with London white sugar hitting a five-year low, as robust harvests from Brazil and India signal a prolonged period of ample global supplies.
Morgan Stanley's top strategist argues that recent U.S. trade shifts have prompted nations worldwide to reassess and leverage their own economic strengths, creating a multi-year investment opportunity in a more multipolar global order.
After a sharp January sell-off, Shopify's stock is hovering near a significant long-term trendline—a level that has preceded notable rallies in the past.
CNBC's Jim Cramer expressed reservations about aviation services provider AAR Corp., highlighting its 15% gross yield as a potential red flag for investors during a recent market analysis segment.
Business Facilities magazine has named North Carolina its 'State of the Year' for business climate and economic development, the state's third such win in six years, following a surge of multi-billion dollar investments from tech and manufacturing giants.
Personal finance icon Suze Orman echoes a timeless principle from Napoleon Hill's 'Think and Grow Rich': the battle for wealth is won or lost in the mind. Experts argue that self-doubt, not market conditions, is the primary barrier most people face.
The rapid adoption of algorithmic decision-making in UK banks has created a critical lag in oversight and accountability structures, leaving institutions exposed to risks that traditional governance models are ill-equipped to manage.
Wall Street analysts have issued a revised price target for Lucid Group (LCID), reflecting updated assessments of the electric vehicle maker's execution risks, funding runway, and demand trajectory. The shift underscores the evolving narrative around the company's ability to scale amid intense competition and macroeconomic headwinds.
BioNTech's stock faces pressure following a Leerink Partners downgrade, which tempered near-term optimism around its oncology pipeline after a recent rally. The move highlights investor reassessment of catalysts amid mixed long-term performance.
Swiss banking giant UBS is preparing to offer a limited group of its wealth management clients access to trade Bitcoin and Ether, marking a significant but measured step into digital assets as it responds to client demand and a shifting regulatory landscape.
As BHP Group advances plans to create one of the world's first fully autonomous copper mines at Escondida Norte, it simultaneously contends with Chinese import restrictions on its Jimblebar iron ore and ramps up exploration via its 2026 Xplor program, highlighting the complex balancing act facing the global mining giant.
